Valeant To Buy Branded Generics Assets From Gerot Lannach

Date : 03/13/2012 @ 9:34AM
Source : Dow Jones News
Stock : Valeant Pharmaceuticals International, Inc. (VRX)
Quote : 9.25  -0.13 (-1.39%) @ 7:57PM

Valeant To Buy Branded Generics Assets From Gerot Lannach

Valeant Pharma (NYSE:VRX)
Historical Stock Chart

5 Years : From Apr 2012 to Apr 2017

Click Here for more Valeant Pharma Charts.

Valeant Pharmaceuticals International Inc. (VRX) said Tuesday it's acquiring from Austria's Gerot Lannach certain branded generics assets that generate the bulk of their sales in Russia.

Mississauga, Ont.-based Valeant said the assets generated net revenue of about $55 million last year. Gerot Lannach's largest product is acetylsalicylic acid, a low-dose aspirin.

Valeant said it will pay less than three times sales, and may make up to an additional $20 million in milestone payments, based upon future performance objectives.

As part of the transaction, Valeant and Gerot Lannach will enter into a strategic partnership that includes an exclusive 10-year supply agreement for the acquired products and the opportunity for Valeant to introduce additional Gerot Lannach products into Valeant territories such as its emerging markets in Southeast Asia and Latin America.

Valeant expects the transaction to boost results starting immediately.

-By Carolyn King, Dow Jones Newswires; 416-306-2100; carolyn.m.king@dowjones.com




Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.